Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.49 | -$1.47 | -$1.48 |
| Q2 2026 | 1 | -$1.22 | -$1.21 | -$1.22 |
| Q3 2026 | 1 | -$0.95 | -$0.95 | -$0.95 |
| Q4 2026 | 1 | -$0.95 | -$0.95 | -$0.95 |
| Q1 2027 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q2 2027 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q3 2027 | 1 | -$0.89 | -$0.89 | -$0.89 |
| Q4 2027 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q1 2028 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q2 2028 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q3 2028 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q4 2028 | 1 | -$0.52 | -$0.52 | -$0.52 |
DarioHealth Corp last posted its earnings results on Tuesday, August 11th, 2026. The company reported $-0.85 earnings per share for the quarter, topping analysts' consensus estimates of $-1.22 by $0.37. The company had revenue of 5.18 M for the quarter and had revenue of 22.36 M for the year. DarioHealth Corp has generated $-1 earnings per share over the last year ($-0.81 diluted earnings per share) and currently has a price-to-earnings ratio of 10.86. DarioHealth Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2026 | Q2 2026 | -$1.22 | -$0.85 | 0.37 | $5.92 M | $5.18 M |
| 05/13/2026 | Q1 2026 | -$1.09 | -$0.17 | 0.92 | $5.46 M | $5.58 M |
| 03/19/2026 | Q4 2025 | -$2.44 | $1.90 | 4.34 | $5.05 M | $5.23 M |
| 11/13/2025 | Q3 2025 | -$3.97 | -$0.19 | 3.78 | $5.67 M | $5.01 M |
| 08/12/2025 | Q2 2025 | -$2.20 | -$0.20 | 2 | $6.91 M | $5.37 M |
| 05/14/2025 | Q1 2025 | -$1.40 | -$0.31 | 1.09 | $7.47 M | $6.75 M |
| 03/10/2025 | Q4 2024 | -$0.24 | -$0.26 | -0.02 | $7.39 M | $7.60 M |
| 11/07/2024 | Q3 2024 | -$3.60 | -$0.25 | 3.35 | $7.40 M | $7.42 M |
| 08/08/2024 | Q2 2024 | -$0.56 | -$0.08 | 0.48 | $7.92 M | $6.26 M |
| 05/15/2024 | Q1 2024 | -$5.90 | -$0.20 | 5.7 | $6.76 M | $5.76 M |
| 03/28/2024 | Q4 2023 | N/A | -$0.44 | N/A | $3.78 M | $3.62 M |
| 11/02/2023 | Q3 2023 | -$0.53 | -$0.49 | 0.04 | $5.42 M | $3.52 M |
| 08/10/2023 | Q2 2023 | -$0.52 | -$0.59 | -0.07 | $6.50 M | $6.15 M |
| 05/11/2023 | Q1 2023 | -$0.50 | -$0.47 | 0.03 | $6.70 M | $7.07 M |
| 03/09/2023 | Q4 2022 | -$0.61 | -$0.49 | 0.12 | $6.71 M | $6.81 M |
| 11/14/2022 | Q3 2022 | -$0.76 | -$0.73 | 0.03 | $6.29 M | $6.61 M |
| 08/15/2022 | Q2 2022 | -$15.09 | -$0.80 | 14.29 | $8.25 M | $6.18 M |
| 05/11/2022 | Q1 2022 | -$0.96 | -$0.81 | 0.15 | $6.82 M | $8.06 M |
| 03/21/2022 | Q4 2021 | -$22.60 | -$1.38 | 21.22 | $6.02 M | $6.03 M |
| 11/15/2021 | Q3 2021 | -$19.00 | -$1.36 | 17.64 | $5.77 M | $5.63 M |
In the previous quarter, DarioHealth Corp (:DRIO) reported $-0.85 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.22 by $0.37.
The conference call for DarioHealth Corp's latest earnings report can be listened to online.
The conference call transcript for DarioHealth Corp's latest earnings report can be read online.
DarioHealth Corp (:DRIO) has a recorded annual revenue of $22.36 M.
DarioHealth Corp (:DRIO) has a recorded net income of $-41,714,000.DarioHealth Corp has generated $-0.81 earnings per share over the last four quarters.
DarioHealth Corp (:DRIO) has a price-to-earnings ratio of 10.86 and price/earnings-to-growth ratio is 0.11.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED